☰

Matthew J. Riese, Ph.D. - Publications

Affiliations: 
2002 Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Microbiology Biology
Tree Info Similar researchers PubMed Report error

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Gu J, Wang C, Cao C, Huang J, Holzhauer S, Desilva H, Wesley EM, Evans DB, Benci J, Wichroski M, Wee S, Riese MJ. DGKζ exerts greater control than DGKα over CD8 T cell activity and tumor inhibition. Oncoimmunology. 10: 1941566. PMID 34350062 DOI: 10.1080/2162402X.2021.1941566  0.307
2021 Kumar J, Kumar R, Kumar Singh A, Tsakem EL, Kathania M, Riese MJ, Theiss AL, Davila ML, Venuprasad K. Deletion of Cbl-b inhibits CD8 T-cell exhaustion and promotes CAR T-cell function. Journal For Immunotherapy of Cancer. 9. PMID 33462140 DOI: 10.1136/jitc-2020-001688  0.301
2020 Gerbec ZJ, Hashemi E, Nanbakhsh A, Holzhauer S, Yang C, Mei A, Tsaih SW, Lemke A, Flister MJ, Riese MJ, Thakar MS, Malarkannan S. Conditional Deletion of PGC-1α Results in Energetic and Functional Defects in NK Cells. Iscience. 23: 101454. PMID 32858341 DOI: 10.1016/J.Isci.2020.101454  0.345
2020 Yang C, Siebert JR, Burns R, Zheng Y, Mei A, Bonacci B, Wang D, Urrutia RA, Riese MJ, Rao S, Carlson KS, Thakar MS, Malarkannan S. Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature. Elife. 9. PMID 32406817 DOI: 10.7554/Elife.51339  0.365
2020 Yang C, Siebert JR, Burns R, Zheng Y, Mei A, Bonacci B, Wang D, Urrutia RA, Riese MJ, Rao S, Carlson K, Thakar MS, Malarkannan S. Author response: Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature Elife. DOI: 10.7554/Elife.51339.Sa2  0.351
2019 Sitaram P, Uyemura B, Malarkannan S, Riese MJ. Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity. International Journal of Molecular Sciences. 20. PMID 31756921 DOI: 10.3390/Ijms20235821  0.449
2019 Fong L, Hotson A, Powderly J, Sznol M, Heist RS, Choueiri TK, George S, Hughes BG, Hellmann MD, Shepard DR, Rini BI, Kummar S, Weise AM, Riese MJ, Markman B, et al. Adenosine A2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. Cancer Discovery. PMID 31732494 DOI: 10.1158/2159-8290.Cd-19-0980  0.365
2019 Nanbakhsh A, Srinivasamani A, Holzhauer S, Riese MJ, Zheng Y, Wang D, Burns R, Reimer MH, Rao S, Lemke A, Tsaih SW, Flister MJ, Lao S, Dahl R, Thakar MS, et al. Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells. Cancer Immunology Research. PMID 31515257 DOI: 10.1158/2326-6066.Cir-18-0934  0.364
2019 Singh BK, Lu W, Schmidt Paustian AM, Ge MQ, Koziol-White CJ, Flayer CH, Killingbeck SS, Wang N, Dong X, Riese MJ, Deshpande DA, Panettieri RA, Haczku A, Kambayashi T. Diacylglycerol kinase ζ promotes allergic airway inflammation and airway hyperresponsiveness through distinct mechanisms. Science Signaling. 12. PMID 31481522 DOI: 10.1126/Scisignal.Aax3332  0.308
2019 Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, Routes JM, Verbsky JW, Thakar MS, Malarkannan S. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nature Communications. 10: 3931. PMID 31477722 DOI: 10.1038/S41467-019-11947-7  0.344
2019 Jing W, McAllister D, Vonderhaar EP, Palen K, Riese MJ, Gershan J, Johnson BD, Dwinell MB. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. Journal For Immunotherapy of Cancer. 7: 115. PMID 31036082 DOI: 10.1186/S40425-019-0573-5  0.353
2019 Wee S, Gu J, Wang C, Cao C, Holzhauer S, Desilva H, Wesley E, Tsai S, Evans D, Riese M. Abstract 936: Regulation of CD8+ T-cell function and antitumor activity by DGKα and DGKζ Cancer Research. 79: 936-936. DOI: 10.1158/1538-7445.Am2019-936  0.451
2018 Bajor DL, Mick R, Riese MJ, Huang AC, Sullivan B, Richman LP, Torigian DA, George SM, Stelekati E, Chen F, Melenhorst JJ, Lacey SF, Xu X, Wherry EJ, Gangadhar TC, et al. Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma. Oncoimmunology. 7: e1468956. PMID 30288340 DOI: 10.1080/2162402X.2018.1468956  0.324
2018 Newman DK, Fu G, McOlash L, Schauder D, Newman PJ, Cui W, Rao S, Johnson BD, Gershan JA, Riese MJ. Frontline Science: PECAM-1 (CD31) expression in naïve and memory, but not acutely activated, CD8 T cells. Journal of Leukocyte Biology. PMID 30063264 DOI: 10.1002/Jlb.2Hi0617-229Rrr  0.363
2018 Nanbakhsh A, Best B, Riese M, Rao S, Wang L, Medin J, Thakar MS, Malarkannan S. Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells. Journal of Visualized Experiments : Jove. PMID 29364266 DOI: 10.3791/55063  0.343
2018 Vaena DA, Chaves J, Vogelzang NJ, Matrana MR, Gabayan AE, Riese MJ, Cho DC, Tagliaferri MA, Zalevsky J, Xie S, Hoch U, RIZWAN AN, Aung S, Imperiale M, Schwarz JK. PROPEL: A phase 1/2 trial of NKTR-214 (CD122-biased agonist) combined with anti-PD-1 (pembrolizumab) or anti-PD-L1 (atezolizumab) in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. 36: TPS3115-TPS3115. DOI: 10.1200/Jco.2018.36.15_Suppl.Tps3115  0.341
2018 Daud A, Saleh MN, Hu J, Bleeker JS, Riese MJ, Meier R, Zhou L, Serbest G, Lewis KD. Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study. Journal of Clinical Oncology. 36: 9511-9511. DOI: 10.1200/Jco.2018.36.15_Suppl.9511  0.3
2017 Jing W, Gershan JA, Holzhauer S, Weber J, Palen K, McOlash L, Pulakanti K, Wesley E, Rao S, Johnson BD, Riese MJ. T cells deficient in diacylglycerol kinase-ζ are resistant to PD-1 inhibition and help create persistent host immunity to leukemia. Cancer Research. PMID 28916658 DOI: 10.1158/0008-5472.Can-17-1309  0.379
2017 Jing W, Gershan JA, Blitzer GC, Palen K, Weber J, McOlash L, Riese M, Johnson BD. Adoptive cell therapy using PD-1(+) myeloma-reactive T cells eliminates established myeloma in mice. Journal For Immunotherapy of Cancer. 5: 51. PMID 28642819 DOI: 10.1186/S40425-017-0256-Z  0.349
2016 Riese MJ, Moon EK, Johnson BD, Albelda SM. Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in Cancer. Frontiers in Cell and Developmental Biology. 4: 108. PMID 27800476 DOI: 10.3389/Fcell.2016.00108  0.416
2016 Rajasekaran K, Riese MJ, Rao S, Wang L, Thakar MS, Sentman CL, Malarkannan S. Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy. Frontiers in Immunology. 7: 176. PMID 27242783 DOI: 10.3389/Fimmu.2016.00176  0.339
2016 Newman DK, Fu G, Adams T, Cui W, Arumugam V, Bluemn T, Riese MJ. The adhesion molecule PECAM-1 enhances the TGF-β-mediated inhibition of T cell function. Science Signaling. 9: ra27. PMID 26956486 DOI: 10.1126/Scisignal.Aad1242  0.357
2015 Arumugam V, Bluemn T, Wesley E, Schmidt AM, Kambayashi T, Malarkannan S, Riese MJ. TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β. Journal of Leukocyte Biology. PMID 26153417 DOI: 10.1189/Jlb.2Hima1214-578R  0.339
2015 Schmidt AM, Lu W, Sindhava VJ, Huang Y, Burkhardt JK, Yang E, Riese MJ, Maltzman JS, Jordan MS, Kambayashi T. Regulatory T cells require TCR signaling for their suppressive function. Journal of Immunology (Baltimore, Md. : 1950). 194: 4362-70. PMID 25821220 DOI: 10.4049/Jimmunol.1402384  0.429
2015 Abel AM, Schuldt KM, Rajasekaran K, Hwang D, Riese MJ, Rao S, Thakar MS, Malarkannan S. IQGAP1: insights into the function of a molecular puppeteer. Molecular Immunology. 65: 336-49. PMID 25733387 DOI: 10.1016/J.Molimm.2015.02.012  0.378
2015 Newman D, Adams T, Arumugam V, Bluemn T, Fu G, Riese M. Novel role of platelet endothelial cell adhesion molecule-1 (PECAM-1) in facilitating TGF-beta-mediated inhibition of T cell function Journal For Immunotherapy of Cancer. 3: P242. DOI: 10.1186/2051-1426-3-S2-P242  0.46
2015 Bajor DL, Mick R, Riese MJ, Lee RP, Xu X, Torigian DA, Stelekati E, Sweeney M, Sullivan BJ, Schuchter LM, Amaravadi R, Wherry EJ, Vonderheide RH. Abstract A38: Phase I study of combination immunotherapy with agonistic CD40 monoclonal antibody (mAb) CP-870,893 (αCD40) and anti-CTLA-4 antibody tremelimumab (treme) in patients with metastatic melanoma Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A38  0.349
2015 Bajor DL, Mick R, Riese MJ, Richman LP, Xu X, Torigian DA, Stelekati E, Sweeney M, Sullivan B, Schuchter LM, Amaravadi R, Wherry EJ, Vonderheide RH. Abstract CT137: Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct137  0.355
2013 Wang LC, Riese MJ, Moon EK, Albelda SM. Overcoming intrinsic inhibitory pathways to augment the antineoplastic activity of adoptively transferred T cells: Re-tuning your CAR before hitting a rocky road. Oncoimmunology. 2: e26492. PMID 24490126 DOI: 10.4161/Onci.26492  0.408
2013 Joshi RP, Schmidt AM, Das J, Pytel D, Riese MJ, Lester M, Diehl JA, Behrens EM, Kambayashi T, Koretzky GA. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling. Science Signaling. 6: ra102. PMID 24280043 DOI: 10.1126/Scisignal.2004373  0.443
2013 Riese MJ, Wang LC, Moon EK, Joshi RP, Ranganathan A, June CH, Koretzky GA, Albelda SM. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases. Cancer Research. 73: 3566-77. PMID 23576561 DOI: 10.1158/0008-5472.Can-12-3874  0.444
2013 Riese M, Wang L, Ranganathan A, Koretzky G, Albelda S. Abstract A3: Enhanced effector responses in CAR-redirected CD8+ T cells deficient in diacylglycerol kinases. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-A3  0.44
2011 Wu GF, Corbo E, Schmidt M, Smith-Garvin JE, Riese MJ, Jordan MS, Laufer TM, Brown EJ, Maltzman JS. Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses. European Journal of Immunology. 41: 2064-73. PMID 21469089 DOI: 10.1002/Eji.201040809  0.432
2011 Riese MJ, Grewal J, Das J, Zou T, Patil V, Chakraborty AK, Koretzky GA. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses. The Journal of Biological Chemistry. 286: 5254-65. PMID 21138839 DOI: 10.1074/Jbc.M110.171884  0.436
2010 Riese M, Koretzky G. Effects of Diacylglycerol Kinase-ζ Deficiency on CD8+ T Cell Function Clinical Immunology. 135: S12. DOI: 10.1016/J.Clim.2010.03.042  0.35
2008 Janzen V, Fleming HE, Riedt T, Karlsson G, Riese MJ, Lo Celso C, Reynolds G, Milne CD, Paige CJ, Karlsson S, Woo M, Scadden DT. Hematopoietic stem cell responsiveness to exogenous signals is limited by caspase-3. Cell Stem Cell. 2: 584-94. PMID 18522851 DOI: 10.1016/J.Stem.2008.03.012  0.364
2003 Maresso AW, Riese MJ, Barbieri JT. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S. Biochemistry. 42: 14249-57. PMID 14640693 DOI: 10.1021/Bi035053I  0.675
2002 Pederson KJ, Krall R, Riese MJ, Barbieri JT. Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins. Molecular Microbiology. 46: 1381-90. PMID 12453223 DOI: 10.1046/J.1365-2958.2002.03256.X  0.599
2002 Barbieri JT, Riese MJ, Aktories K. Bacterial toxins that modify the actin cytoskeleton. Annual Review of Cell and Developmental Biology. 18: 315-44. PMID 12142277 DOI: 10.1146/Annurev.Cellbio.18.012502.134748  0.522
2002 Fraylick JE, Riese MJ, Vincent TS, Barbieri JT, Olson JC. ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA. Biochemistry. 41: 9680-7. PMID 12135390 DOI: 10.1021/Bi025826N  0.586
2002 Riese MJ, Barbieri JT. Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS. Infection and Immunity. 70: 2230-2. PMID 11895993 DOI: 10.1128/Iai.70.4.2230-2232.2002  0.547
2002 Riese MJ, Goehring UM, Ehrmantraut ME, Moss J, Barbieri JT, Aktories K, Schmidt G. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS. The Journal of Biological Chemistry. 277: 12082-8. PMID 11821389 DOI: 10.1074/Jbc.M109039200  0.582
2001 Riese MJ, Wittinghofer A, Barbieri JT. ADP ribosylation of Arg41 of Rap by ExoS inhibits the ability of Rap to interact with its guanine nucleotide exchange factor, C3G. Biochemistry. 40: 3289-94. PMID 11258948 DOI: 10.1021/Bi002729Q  0.567
Show low-probability matches.